Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2006

View Archived Issues

Studies delineate armodafinil effects in patients with sleep disorders

Affymetrix and Invitrogen sign licensing agreement

Preliminary results from phase II studies of cocaine vaccine TA-CD

Azedra studied for treatment of neuroendocrine tumors

Advancis signs contract sales agreement with Innovex

Pierre Fabre and Millenia Hope team up

MediGene receives German grant for EndoTAG technology

Merrion and Roche collaborate on oral drug delivery feasibility study

Preclinical characterization of rivoglitazone and its effects on adiponectin in healthy subjects

Pharmacokinetics and efficacy of the DPP-IV inhibitor, PSN-9301, in patients with type 2 diabetes

Pharmacokinetics, safety and efficacy of BIM-51077 in dogs and patients with type 2 diabetes

Enrollment completed in Nebido PK study

Merck, Sharp & Dohme report on new GABA-A alpha3 modulators

Higher dose regimen of removab yields tumor response

Positive phase II results for ALTU-238 in growth hormone deficient adults

IND filing for study of VivaGel for prevention of genital herpes

deCODE updates pipeline progress

MorphoSys and Novartis expand therapeutic antibody collaboration

ANA-975 dosing suspended pending analysis of preclinical findings

Novelos' acute radiation syndrome proposal to be studied further by DHHS

Phase III Avastin study in advanced pancreatic cancer fails to meet endpoint

Highlights of dasatinib studies from the European Hematology Association meeting

Models show potential of hLF1-11 as anti-infective in stem cell transplant patients

Topical retapamulin effective in secondarily infected dermatitis

Exelon, first FDA approved treatment for Parkinson's disease dementia

Neutralizing GM-CSF shows potential to treat inflammatory diseases

Chemokine CCR5 receptor ligands for HIV patented by ViroChem Pharma

New treatment options for cardiovascular disorders reported in recent patent literature

Patent claims use of telithromycin in acute exacerbations of asthma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...